Every year the Canadian Cancer Society honours 10 world-class research studies funded by the society. One of the 2015 selections showed that a steroid called dexamethasone can reduce the temporary pain caused by the radiation treatment given to patients whose cancer has spread to their bones. This randomized, placebo-controlled trial published in The Lancet Oncology was organized by the Canadian Cancer Trials Group, and brought together nearly 300 patients at 23 centres across Canada. Dr. Kristopher Dennis led the local arm of the study. The study concluded that dexamethasone should be part of standard care for bone metastases, and could change how advanced cancer is managed worldwide.
Authors: Edward Chow, Ralph M Meyer, Keyue Ding, Abdenour Nabid, Pierre Chabot, Philip Wong, Shahida Ahmed, Joda Kuk, A Rashid Dar, Aamer Mahmud, Alysa Fairchild, Carolyn F Wilson, Jackson S Y Wu, Kristopher Dennis, Michael Brundage, Carlo DeAngelis, Rebecca K S Wong.
About The Ottawa Hospital
The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care.
For further information, please contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73325
Cell: 613-614-5253
jganton@ohri.ca
